Weighted Average Number of Shares Outstanding, Basic of GT Biopharma, Inc. from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
GT Biopharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 5,513,255, a 191% increase year-over-year.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 5,513,255, a 191% increase from 2024.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,897,375, a 41% increase from 2023.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1,347,713, a 27% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 5,513,255 +3,615,880 +191% 01 Oct 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 3,940,714 +1,706,386 +76% 01 Jul 2025 30 Sep 2025 10-Q/A 06 Mar 2026 2025 Q3
Q2 2025 2,771,765 +1,059,810 +62% 01 Apr 2025 30 Jun 2025 10-Q/A 06 Mar 2026 2025 Q2
Q1 2025 2,345,087 +964,454 +70% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,897,375 +549,662 +41% 01 Oct 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 2,234,328 +867,122 +63% 01 Jul 2024 30 Sep 2024 10-Q/A 06 Mar 2026 2025 Q3
Q2 2024 1,711,955 +372,868 +28% 01 Apr 2024 30 Jun 2024 10-Q/A 06 Mar 2026 2025 Q2
Q1 2024 1,380,633 +297,762 +27% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 1,347,713 +285,446 +27% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 1,367,206 -30,013,428 -96% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 1,339,087 -29,898,473 -96% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 1,082,871 -31,403,245 -97% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 1,062,267 -27,093,357 -96% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 31,380,634 -648 -0% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 31,237,560 -2,278,868 -6.8% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 32,486,116 +16,246,178 +100% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 28,155,624 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 31,381,282 01 Jul 2021 30 Sep 2021 10-Q 31 Oct 2022 2022 Q3
Q2 2021 33,516,428 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 16,239,938 -53,837,088 -77% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 70,077,026 +18,984,140 +37% 01 Jan 2020 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q1 2019 51,092,886 +974,909 +1.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 50,240 +33,471 +200% 01 Oct 2018 31 Dec 2018 10-K 29 Mar 2019 2018 FY
Q3 2018 50,154,516 +34,126,829 +213% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 -0* +5 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 50,117,977 +49,926,130 +26024% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 16,769 -64,691 -79% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 16,027,687 -11,434,424 -42% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 -5* -23,335,608 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 191,847 -17,223,342 -99% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 81,460 -2,313,080 -97% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 27,462,111 +25,062,111 +1044% 01 Jul 2016 30 Sep 2016 10-Q/A 28 Feb 2018 2016 Q3
Q2 2016 23,335,603 +20,939,222 +874% 01 Apr 2016 30 Jun 2016 10-Q/A 28 Feb 2018 2016 Q2
Q1 2016 17,415,189 +15,033,410 +631% 01 Jan 2016 31 Mar 2016 10-Q/A 28 Feb 2018 2016 Q1
Q4 2015 2,394,540 01 Oct 2015 31 Dec 2015 10-K/A 28 Feb 2018 2016 FY
Q3 2015 2,400,000 -587,655,554 -100% 01 Jul 2015 30 Sep 2015 10-Q/A 28 Feb 2018 2016 Q3
Q2 2015 2,396,381 -570,655,143 -100% 01 Apr 2015 30 Jun 2015 10-Q/A 28 Feb 2018 2016 Q2
Q1 2015 2,381,779 -570,669,745 -100% 01 Jan 2015 31 Mar 2015 10-Q/A 28 Feb 2018 2016 Q1
Q3 2014 590,055,554 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2015 Q3
Q2 2014 573,051,524 0 0% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 573,051,524 +25,803,704 +4.7% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q2 2013 573,051,524 +243,779,159 +74% 01 Apr 2013 30 Jun 2013 10-Q 08 Jan 2015 2014 Q3
Q1 2013 547,247,820 +264,266,663 +93% 01 Jan 2013 31 Mar 2013 10-Q 08 Jan 2015 2014 Q1
Q2 2012 329,272,365 01 Apr 2012 30 Jun 2012 10-Q 12 Dec 2014 2013 Q2
Q1 2012 282,981,157 01 Jan 2012 31 Mar 2012 10-Q 10 Dec 2014 2013 Q1

GT Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 5,513,255 +3,615,880 +191% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 1,897,375 +549,662 +41% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 1,347,713 +285,446 +27% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 1,062,267 -27,093,357 -96% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 28,155,624 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2018 50,240 +33,471 +200% 01 Jan 2018 31 Dec 2018 10-K 29 Mar 2019 2018 FY
2017 16,769 -64,691 -79% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
2016 81,460 -2,313,080 -97% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2018 2017 FY
2015 2,394,540 01 Jan 2015 31 Dec 2015 10-K/A 28 Feb 2018 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.